Albuterol
Result: $150 million settlement
Year: 1995
In re Copley Pharmaceutical, Inc., “Albuterol” Products Liability Litigation
Lieff Cabraser served on the Plaintiffs’ Steering Committee in a class action lawsuit against Copley Pharmaceutical, which manufactured Albuterol, a bronchodilator prescription pharmaceutical. Albuterol was the subject of a nationwide recall in January 1994 after a microorganism was found to have contaminated the solution, allegedly causing numerous injuries including bronchial infections, pneumonia, respiratory distress and, in some cases, death.
In October 1994, the district court certified a nationwide class on liability issues. In re Copley Pharmaceutical, 161 F.R.D. 456 (D. Wyo. 1995). In November 1995, the district court approved a $150 million settlement of the litigation.
Civil Litigation News
Lieff Cabraser and Kaplan Gore Announce Filing of Federal Class Action Lawsuit Against Google Over the Defective Google Nest Hub, Google Nest Hub Max, Google Nest Mini, and Google Nest Audio Devices
Complaint alleges that Google induced plaintiffs and other customers to spend hundreds of dollars or more each to purchase Google Nest Hub,
Douglas Cuthbertson to Discuss “Consumer Data Privacy” at Upcoming NASCAT Annual Meeting
Lieff Cabraser partner Douglas Cuthbertson will be a featured speaker at the 2025 NASCAT annual meeting. Doug will be speaking on the
San Francisco Schools Receive Financial Boost From Settlement With JUUL
As reported by the S.F. Chronicle, the San Francisco Unified School District has been awarded a substantial $24.65












